| Paneth cells of the human small intestine express an antimicrobial peptide gene DE Jones, CL Bevins Journal of Biological Chemistry 267 (32), 23216-23225, 1992 | 704 | 1992 |
| Defensin-6 mRNA in human Paneth cells: implications for antimicrobia peptides in host defense of the human bowel DE Jones, CL Bevins Febs Letters 315 (2), 187-192, 1993 | 440 | 1993 |
| Enteric β-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection AP Tarver, DP Clark, G Diamond, JP Russell, H Erdjument-Bromage, ... Infection and Immunity 66 (3), 1045-1056, 1998 | 240 | 1998 |
| Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. G Diamond, DE Jones, CL Bevins Proceedings of the National Academy of Sciences 90 (10), 4596-4600, 1993 | 227 | 1993 |
| Early Induction of Humoral and Cellular Immune Responses during Experimental Mycobacterium avium subsp. paratuberculosis Infection of Calves WR Waters, JM Miller, MV Palmer, JR Stabel, DE Jones, KA Koistinen, ... Infection and immunity 71 (9), 5130-5138, 2003 | 222 | 2003 |
| Programmed death 1–mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function KJ Esch, R Juelsgaard, PA Martinez, DE Jones, CA Petersen The Journal of Immunology 191 (11), 5542-5550, 2013 | 184 | 2013 |
| Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide RM Mukbel, C Patten, K Gibson, M Ghosh, C Petersen, DE Jones The American journal of tropical medicine and hygiene 76 (4), 669-675, 2007 | 174 | 2007 |
| IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection DE Jones, LU Buxbaum, P Scott The Journal of Immunology 165 (1), 364-372, 2000 | 167 | 2000 |
| Early Enhanced Th1 Response after Leishmania amazonensis Infection of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of Infection DE Jones, MR Ackermann, U Wille, CA Hunter, P Scott Infection and immunity 70 (4), 2151-2158, 2002 | 146 | 2002 |
| Immunologic Indicators of Clinical Progression during Canine Leishmania infantum Infection PM Boggiatto, AE Ramer-Tait, K Metz, EE Kramer, K Gibson-Corley, ... Clinical and Vaccine Immunology 17 (2), 267-273, 2010 | 130 | 2010 |
| Interferon-γ and interleukin 4 gene expression in cows infected with Mycobacterium paratuberculosis RW Sweeney, DE Jones, P Habecker, P Scott American journal of veterinary research 59 (7), 842-847, 1998 | 124 | 1998 |
| Mathematical modelling of immune response in tissues B Su, W Zhou, KS Dorman, DE Jones Computational and Mathematical Methods in Medicine 10 (1), 9-38, 2009 | 102 | 2009 |
| Human enteric defensin genes: chromosomal map position and a model for possible evolutionary relationships CL Bevins, DE Jones, A Dutra, J Schaffzin, M Muenke Genomics 31 (1), 95-106, 1996 | 102 | 1996 |
| Differential Regulation of the Interleukin-12 Receptor during the Innate Immune Response to Leishmania major D Jones, MM Elloso, L Showe, D Williams, G Trinchieri, P Scott Infection and immunity 66 (8), 3818-3824, 1998 | 99 | 1998 |
| Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance JH Whittaker, SA Carlson, DE Jones, MT Brewer Journal of Veterinary Pharmacology and Therapeutics 40 (2), 105-115, 2017 | 85 | 2017 |
| The Immunology of Leishmania Infection and the Implications for Vaccine Development Y Vanloubbeeck, DE Jones Annals of the New York Academy of Sciences 1026 (1), 267-272, 2004 | 75 | 2004 |
| L. Paula o, CJ Pickard, W. Poelmans, MIJ Probert, K. Refson, M. Richter, G K Lejaeghere, G Bihlmayer, T Björkman, P Blaha, S Blügel, V Blum, ... M. Rignanese, S. Saha, M. Sche ler, M. Schlipf, K. Schwarz, S. Sharma, F …, 2016 | 63 | 2016 |
| Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection GM Dancik, DE Jones, KS Dorman Journal of Theoretical Biology 262 (3), 398-412, 2010 | 57 | 2010 |
| Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response. BD Hondowicz, TM Scharton-Kersten, DE Jones, P Scott Journal of immunology (Baltimore, Md.: 1950) 159 (10), 5024-5031, 1997 | 57 | 1997 |
| Host susceptibility factors to cutaneous leishmaniasis DE Jones, MM Elloso, P Scott Front. Biosci 3, D1171-D1180, 1998 | 55 | 1998 |
